Abstract
Stage ⅢA non-small cell lung cancer (NSCLC) has high heterogeneity and there are some controversies over the treatment of this disease, especially for patients with stage ⅢA—N2 NSCLC. This article investigates whether preoperative or postoperative radiotherapy can improve the survival of patients with stage ⅢA—N2 NSCLC and evaluates the effect of surgical treatment. Key words: Carcinoma, non-small cell lung/surgery; Carcinoma, non-small cell lung/radiotherapy; ⅢA—N2 stage
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
